Browse by category

Stopping weight loss drugs is followed by weight regain and reversal of beneficial effects on heart and metabolic health markers such as high cholesterol and high blood pressure, according to a study by University of Oxford researchers. The study shows that the average rate of weight regain is 0.4kg/month after stopping treatment, with weight and risk markers for diabetes and heart disease predicted to return to pre-treatment levels in less than two years. It also finds that

Transoral outlet reduction (TORe) and anastomotic reduction techniques are gaining momentum as minimally invasive alternatives to surgical revision for managing post-surgical complications such as weight regain and dumping syndrome.(1) BARS® — a novel endoscopic platform developed by Ovesco Endoscopy AG — is among the emerging technologies in this field. As clinical experience with BARS® grows, early data on weight regain management and targeted treatment approaches for enlar

Two years after the start of the COVID-19 pandemic, bariatric surgery patients showed an increase in the percentage of weight regain and...

A study by the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC) research team that...

Superobesity - The researchers wanted to find out whether behavioural and cognitive factors before and after bariatric surgery might...

In a wide-ranging interview, Bariatric News talked to Mr Shaw Somers, upper gastrointestinal and bariatric (metabolic) Consultant Surgeon...